SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-24-009540
Filing Date
2024-03-11
Accepted
2024-03-11 20:59:54
Documents
1
Period of Report
2024-03-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 15033
  Complete submission text file 0001127602-24-009540.txt   16529
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Issuer) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 333 LAKESIDE DRIVE FOSTER CITY CA 94404
Business Address
Dickinson Andrew D (Reporting) CIK: 0001310204 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19731 | Film No.: 24739995